Not just a top device, probably the top device. It has more longer term clinical data than any other procedure, and many patent protected features which makes it virtually impossible for other companies to replicate the high efficacy and safety offered by our procedure. The new updates now make this high efficacy and safety accessible to a market of doctors that is 50x larger than before. Not only that, it doesn't actually even need to compete with other devices, as it is the ONLY device that does not tear or stent it can complement virtually every single other procedure, adding efficacy with no downside. As of last year as well reimbursement has changed to significantly favour iTrack Advance over other procedures. I definitely see iTrack Advance quickly becoming a leading MIGS device
- Forums
- ASX - By Stock
- Ann: Response to ASX Aware Query
Not just a top device, probably the top device. It has more...
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.0¢ |
Change
0.005(2.86%) |
Mkt cap ! $41.23M |
Open | High | Low | Value | Volume |
17.5¢ | 18.5¢ | 17.5¢ | $18.60K | 102.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 21284 | 18.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 75284 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 21284 | 0.180 |
3 | 111746 | 0.175 |
5 | 157575 | 0.170 |
4 | 49256 | 0.165 |
8 | 434100 | 0.160 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 75284 | 2 |
0.200 | 93423 | 2 |
0.205 | 15050 | 1 |
0.215 | 304291 | 5 |
0.220 | 23255 | 1 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |